<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OTO</journal-id>
<journal-id journal-id-type="hwp">spoto</journal-id>
<journal-title>Otolaryngology–Head and Neck Surgery</journal-title>
<issn pub-type="ppub">0194-5998</issn>
<issn pub-type="epub">1097-6817</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0194599812458771</article-id>
<article-id pub-id-type="publisher-id">10.1177_0194599812458771</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Systematic Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Effectiveness of Repetitive Transcranial Magnetic Stimulation for Chronic Tinnitus</article-title>
<subtitle>A Systematic Review</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Peng</surname><given-names>Zhe</given-names></name>
<degrees>MMed</degrees>
<xref ref-type="aff" rid="aff1-0194599812458771">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Chen</surname><given-names>Xiu-Qi</given-names></name>
<degrees>MMed</degrees>
<xref ref-type="aff" rid="aff2-0194599812458771">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Gong</surname><given-names>Shu-Sheng</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0194599812458771">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0194599812458771"><label>1</label>Department of Otolaryngology, Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China, and Key Laboratory of Otolaryngology, Head and Neck Surgery, Ministry of Education, Beijing Institute of Otolaryngology, Beijing, China</aff>
<aff id="aff2-0194599812458771"><label>2</label>Department of Pediatrics, First Affiliated Hospital, Guangxi Medical University, Nanning, China</aff>
<author-notes>
<corresp id="corresp1-0194599812458771">Shu-Sheng Gong, MD, PhD, Department of Otolaryngology, Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China and Key Laboratory of Otolaryngology, Head and Neck Surgery, Ministry of Education, Beijing Institute of Otolaryngology, Beijing, 100730, China Email: <email>gongshusheng1962@sina.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>11</month>
<year>2012</year>
</pub-date>
<volume>147</volume>
<issue>5</issue>
<fpage>817</fpage>
<lpage>825</lpage>
<history>
<date date-type="received">
<day>12</day>
<month>3</month>
<year>2012</year>
</date>
<date date-type="rev-recd">
<day>16</day>
<month>7</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>7</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Official journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation</copyright-holder>
</permissions>
<abstract>
<sec id="section1-0194599812458771">
<title>Objective</title>
<p>This systematic review aimed to assess the effectiveness of repetitive transcranial magnetic stimulation (rTMS) treatment for chronic tinnitus.</p>
</sec>
<sec id="section2-0194599812458771">
<title>Data Sources</title>
<p>Relevant electronic databases and a reference list of articles published up to January 2012 were searched. Randomized controlled clinical trials of all types of rTMS treatment for patients with chronic tinnitus were included.</p>
</sec>
<sec id="section3-0194599812458771">
<title>Review Methods</title>
<p>A literature search was conducted with structured criteria to select studies evaluated for systematic review.</p>
</sec>
<sec id="section4-0194599812458771">
<title>Results</title>
<p>Five trials (160 participants) were included in this review. Repetitive transcranial magnetic stimulation treatment showed benefits in the short term, but the long-term effects are questionable. The Tinnitus Handicap Inventory (THI) and the visual analog scale (VAS) were the major assessment methods used. After active TMS stimulation, the reduction in the THI total score and VAS was significant compared with baseline at the first time point assessed and in the short term (2 weeks and 4 weeks). The longest follow-up time was 26 weeks after treatment, and the shortest follow-up time was 2 weeks. No severe side effects were reported from the use of rTMS. Differences in age, hearing level, duration of tinnitus of the included patients, and the condition of sham treatment may influence the effect.</p>
</sec>
<sec id="section5-0194599812458771">
<title>Conclusion</title>
<p>Repetitive transcranial magnetic stimulation could be a new therapeutic tool for the treatment of chronic tinnitus, and thus far we have not been able to demonstrate any substantial risk from rTMS treatment. However, the long-term effects of rTMS treatment for tinnitus are not clear and will require further study.</p>
</sec>
</abstract>
<kwd-group>
<kwd>tinnitus</kwd>
<kwd>transcranial magnetic stimulation (TMS)</kwd>
<kwd>therapy</kwd>
<kwd>systematic review</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Tinnitus is a debilitating condition that affects a broad range of patients.<sup><xref ref-type="bibr" rid="bibr1-0194599812458771">1</xref></sup> An estimated 10% to 15% of adults are affected, as determined from data collected in several countries.<sup><xref ref-type="bibr" rid="bibr2-0194599812458771">2</xref><xref ref-type="bibr" rid="bibr3-0194599812458771"/>-<xref ref-type="bibr" rid="bibr4-0194599812458771">4</xref></sup> About 1% to 3% of the population suffers severe impairment of quality of life as a result of tinnitus.<sup><xref ref-type="bibr" rid="bibr5-0194599812458771">5</xref></sup> Tinnitus can cause insomnia and anxiety, which reduce social adaptation. Severe tinnitus can lead to suicide.</p>
<p>Tinnitus is a nonspecific symptom of a hearing disorder characterized by the sensation of buzzing, ringing, clicking, whistling, wind blowing, pulsations, and other noises in the ear.<sup><xref ref-type="bibr" rid="bibr6-0194599812458771">6</xref></sup> Tinnitus may be perceived in one or both ears, within the head or outside the body. In a group of tinnitus patients, 22% reported equal sounds in both ears, and 34% reported experiencing unilateral sounds.<sup><xref ref-type="bibr" rid="bibr6-0194599812458771">6</xref></sup> The symptoms may be continuous or intermittent.</p>
<p>Tinnitus can be divided into 2 main types: objective tinnitus and subjective tinnitus.<sup><xref ref-type="bibr" rid="bibr4-0194599812458771">4</xref></sup> Objective tinnitus, which refers to noises generated from within the ear or adjacent structures that can be heard by other individuals, will not be reviewed in this article. The term <italic>subjective tinnitus</italic> is used when the sound is audible only to the affected individual. Otological causes are the most common causes of subjective tinnitus. These include noise-induced hearing loss, presbycusis, otosclerosis, otitis, cerumen impaction, Ménière’s disease, and sudden sensorineural hearing loss. Despite thorough and extensive research, the cause of tinnitus has yet to be determined.<sup><xref ref-type="bibr" rid="bibr7-0194599812458771">7</xref></sup> The diagnosis of tinnitus should be based on a meticulous history, the psychological state of the patient, a complete head and neck examination, and specialized testing.<sup><xref ref-type="bibr" rid="bibr4-0194599812458771">4</xref>,<xref ref-type="bibr" rid="bibr8-0194599812458771">8</xref></sup></p>
<p>No single intervention has been identified that can consistently eliminate the symptoms of tinnitus. However, despite our inability to “cure” tinnitus, many medical and behavioral strategies may result in symptomatic relief. These management strategies include diet and lifestyle modification, medication and supplements, retraining and masking therapies, and repetitive transcranial magnetic stimulation.<sup><xref ref-type="bibr" rid="bibr7-0194599812458771">7</xref></sup></p>
<p>Transcranial magnetic stimulation (TMS) is a method of stimulating the brain through the intact scalp without causing pain at the surface.<sup><xref ref-type="bibr" rid="bibr9-0194599812458771">9</xref></sup> It is a minimally invasive method for depolarizing cortical neurons based on the principle of electromagnetic induction.<sup><xref ref-type="bibr" rid="bibr10-0194599812458771">10</xref></sup> The rhythmic application of a series of single stimuli is referred to as repetitive TMS (rTMS), a method that has been demonstrated to induce long-term potentiation (LTP) or long-term depression (LTD)–like changes of cortical excitability, which outlast the stimulation period.<sup><xref ref-type="bibr" rid="bibr11-0194599812458771">11</xref></sup> Repetitive TMS has been investigated as a therapeutic tool for depression, schizophrenia, and stroke.<sup><xref ref-type="bibr" rid="bibr12-0194599812458771">12</xref></sup> Recently, multiple studies<sup><xref ref-type="bibr" rid="bibr13-0194599812458771">13</xref><xref ref-type="bibr" rid="bibr14-0194599812458771"/><xref ref-type="bibr" rid="bibr15-0194599812458771"/>-<xref ref-type="bibr" rid="bibr16-0194599812458771">16</xref></sup> have shown that the technique can alleviate tinnitus by modulating the excitability of neurons in the auditory cortex.</p>
<p>In this study, we aimed to assess whether TMS was effective in the management of tinnitus. Since the symptoms of tinnitus are subjective for a great majority of patients, we aimed to evaluate subjective improvement in the perception of these symptoms.</p>
<sec id="section6-0194599812458771" sec-type="methods">
<title>Methods</title>
<list id="list1-0194599812458771" list-type="simple">
<list-item><p><bold>Study design:</bold> Criteria for considering studies for this review</p></list-item>
<list-item><p><bold>Types of studies:</bold> Randomized controlled trials</p></list-item>
<list-item><p><bold>Types of participants:</bold> Adults with a complaint of persistent, distressing, subjective tinnitus of any etiology. We excluded patients with pulsatile tinnitus and other somatic sounds, those with delusional auditory hallucinations, and patients who were undergoing concurrent psychotherapeutic interventions.</p></list-item>
<list-item><p><bold>Types of interventions:</bold> Studies in which patients received rTMS were included. Comparisons performed included the following:
<list id="list2-0194599812458771" list-type="order">
<list-item><p>Repetitive TMS vs placebo</p></list-item>
<list-item><p>Repetitive TMS vs drug/other therapy</p></list-item>
</list></p></list-item></list>
<sec id="section7-0194599812458771">
<title>Search Methods for Identification of Studies</title>
<p>We conducted systematic searches for randomized controlled trials. There were no restrictions on language, publication year, or publication status. The date of the last search was January 2012. We also performed thorough examinations of international reference lists and manually searched the Index Medicus and specialty journals. Certain publication types (ie, letters to the editor, abstracts, proceedings from scientific meetings) were excluded because of a lack of data.</p>
<p>We searched the following electronic databases from their inception: the Cochrane Ear, Nose and Throat Disorders Group Trials Register; the Cochrane Central Register of Controlled Trials (CENTRAL) (<italic>The Cochrane Library</italic> 2009, Issue 3); PubMed; EMBASE; Ovid; CINAHL (Cumulative Index to Nursing and Allied Health Literature); IndMed; PakMediNet; CAB Abstracts; Web of Science; CNKI (China National Knowledge Infrastructure); mRCT (Current Controlled Trials); ClinicalTrials.gov; and ICTRP (International Clinical Trials Registry Platform). The search combined terms related to transcranial magnetic stimulation (magnetic stimulation, transcranial; magnetic stimulations, transcranial; stimulation, transcranial magnetic; stimulations, transcranial magnetic; transcranial magnetic stimulations; transcranial magnetic stimulation, paired pulse; transcranial magnetic stimulation, repetitive; transcranial magnetic stimulation, single pulse) with terms related to tinnitus (tinnitus ear, buzz, ring, roar, click, pulse) and therapy (magnetic field therapy, therapies, magnetic stimulation therapy, treatment). We contacted experts in the specialty and searched the reference lists from primary and review articles.</p>
</sec>
<sec id="section8-0194599812458771">
<title>Types of Outcome Measures</title>
<sec id="section9-0194599812458771">
<title>Primary Outcomes</title>
<p>Patients’ subjective assessment of tinnitus before, during, and after treatment:</p>
<list id="list3-0194599812458771" list-type="order">
<list-item><p>Changes in overall severity of tinnitus and/or impact on quality of life. The questionnaires included the Tinnitus Handicap Inventory (THI),<sup><xref ref-type="bibr" rid="bibr17-0194599812458771">17</xref></sup> the Tinnitus Questionnaire (TQ),<sup><xref ref-type="bibr" rid="bibr18-0194599812458771">18</xref></sup> and the visual analog scale (VAS).</p></list-item>
<list-item><p>Change in loudness of tinnitus.</p></list-item>
</list>
</sec>
<sec id="section10-0194599812458771">
<title>Secondary Outcomes</title>
<list id="list4-0194599812458771" list-type="order">
<list-item><p>Adverse effects (ie, worsening of symptoms, suicidal tendencies, negative thoughts)</p></list-item></list>
</sec>
</sec>
<sec id="section11-0194599812458771">
<title>Data Collection and Analysis</title>
<p>Two review authors (ZP and X-QC) independently selected relevant articles and assessed their eligibility according to the inclusion and exclusion criteria. Any disagreements were resolved by discussion. We checked titles and abstracts and obtained the full text for those articles identified as either relevant or possibly relevant. Only those studies that met the predetermined inclusion criteria were included, and the authors independently extracted data concerning details of patients’ characteristics, study methods, interventions, and outcomes.</p>
</sec>
<sec id="section12-0194599812458771">
<title>Quality Assessment</title>
<p>Two authors (ZP and X-QC) independently assessed methodological quality using the criteria that are described in the <italic>Cochrane Handbook for Systematic Review of Interventions</italic>, including adequate sequence generation, allocation concealment, blinding, whether incomplete outcome data were addressed, and whether the data were free of selective reporting and bias.</p>
</sec>
<sec id="section13-0194599812458771">
<title>Data Extraction and Management</title>
<p>The authors extracted data independently onto standardized data forms. Studies that had incomplete or ambiguous reporting of data were clarified by discussion between the authors.</p>
</sec>
<sec id="section14-0194599812458771">
<title>Assessment of Risk of Bias in Included Studies</title>
<p>The criteria for quality assessment were based on the recommendations of the <italic>Cochrane Handbook for Systematic Reviews of Interventions</italic>, version 4.2.1, Section 6 (updated December 2003).</p>
</sec>
<sec id="section15-0194599812458771">
<title>Data Synthesis</title>
<p>For dichotomous data, we calculated the odds ratio and number needed to treat. For continuous data, we calculated the standardized mean difference. The main analysis was an examination of severity (subjective loudness) of tinnitus and its effect on depression and quality of life, during and after the period of treatment. We also planned to collect and analyze data on any adverse reactions due to treatment.</p>
</sec>
</sec>
<sec id="section16-0194599812458771" sec-type="results">
<title>Results</title>
<sec id="section17-0194599812458771">
<title>Description of Studies</title>
<p>A total of 5 randomized clinical trials were included in the review (<xref ref-type="table" rid="table1-0194599812458771"><bold>Table 1</bold></xref> and <xref ref-type="fig" rid="fig1-0194599812458771"><bold>Figure 1</bold></xref>). Two trials were excluded because the control designs were not randomized, and the Smith et al<sup><xref ref-type="bibr" rid="bibr19-0194599812458771">19</xref></sup> study was excluded because it was a pilot study that was not randomized. The Khedr et al<sup><xref ref-type="bibr" rid="bibr20-0194599812458771">20</xref></sup> study was a comparative study and focused on contralateral vs ipsilateral rTMS for the treatment of tinnitus without a sham group.</p>
<table-wrap id="table1-0194599812458771" position="float">
<label>Table 1.</label>
<caption><p>Inclusion and Exclusion Criteria of Included Trials</p></caption>
<graphic alternate-form-of="table1-0194599812458771" xlink:href="10.1177_0194599812458771-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="2">Study</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="2"><bold>1. Anders et al, 2010<sup><xref ref-type="bibr" rid="bibr24-0194599812458771">24</xref></sup></bold></td>
</tr>
<tr>
<td><bold><italic>Inclusion criteria</italic></bold></td>
<td>Unilateral or bilateral tinnitus of at least 6 months’ duration, pharmacological treatment for at least 3 months without significant clinical response, identical doses of current pharmacological treatment for at least 6 weeks, age-adjusted normal sensorineural hearing determined by audiogram within the last 6 weeks prior to study.</td>
</tr>
<tr>
<td><bold><italic>Exclusion criteria</italic></bold></td>
<td>Concurrent other forms of tinnitus treatments, a history of neuropsychiatric disorder, abnormal electroencephalogram (EEG), intracranial hypertension, history of dizziness, significant head injury, stroke, aneurysm, brain malformation,neurodegenerative disorder affecting the brain, previous cranial neurosurgery, presence of acoustic neuroma, glomustumor, brain tumor, profound hearing loss &gt;90-dB threshold at 4000 Hz or active Ménière’s disease, pacemaker and other metal implants, implanted medication pump, pregnancy, lactation, presence of other significant medical condition, concomitant psychotropic medication or medication that lowers seizure threshold or reduces cortical excitation. Excluded patients with clinically relevant concomitant axis I psychiatric disorders.</td>
</tr>
<tr>
<td colspan="2"><bold>2. Khedr et al, 2008<sup><xref ref-type="bibr" rid="bibr23-0194599812458771">23</xref></sup></bold></td>
</tr>
<tr>
<td><bold><italic>Inclusion criteria</italic></bold></td>
<td>Chronic tinnitus (6 months to 25 years).</td>
</tr>
<tr>
<td><bold><italic>Exclusion criteria</italic></bold></td>
<td>Patients taking anticonvulsant or tranquilizer medication and patients with neurological, psychiatric, or severe systemic disease or with a history of ototoxic drug intake, as well as patients with contraindication for magnetic stimulation.</td>
</tr>
<tr>
<td colspan="2"><bold>3. Marcondes et al, 2010<sup><xref ref-type="bibr" rid="bibr22-0194599812458771">22</xref></sup></bold></td>
</tr>
<tr>
<td><bold><italic>Inclusion criteria</italic></bold></td>
<td>Uni- or bilateral tinnitus of at least 3 months’ duration, age older than18 years and normal pure-tone audiometry(thresholds ≤25 dB hearing level in all frequencies from 250-8000 Hz).</td>
</tr>
<tr>
<td><bold><italic>Exclusion criteria</italic></bold></td>
<td>Neurologic or psychiatric disorders, especially epilepsy, migraine, depression, or anxiety; the intake of antidepressant,neuroleptic, or anticonvulsant drugs; cardiac pacemaker or other implanted devices; intracranial metallic objects;pregnancy, and inability to fulﬁll the study requirements. Comorbid psychiatric diseases. None of the controlsfulﬁlled the criteria of major depression or an anxiety disorder according to the fourth edition of the <italic>Diagnostic andStatistical Manual of Mental Disorders</italic>.</td>
</tr>
<tr>
<td colspan="2"><bold>4. Plewnia et al, 2007<sup><xref ref-type="bibr" rid="bibr25-0194599812458771">25</xref></sup></bold>
</td>
</tr>
<tr>
<td><bold><italic>Inclusion criteria</italic></bold></td>
<td>One woman and 5 men, 49 to 68 years old, with chronic (&gt;1 year) bilateral tinnitus.</td>
</tr>
<tr>
<td><bold><italic>Exclusion criteria</italic></bold></td>
<td>Patients with heart disease, history of seizures or brain lesions, metal implants, cardiac pacemaker, and current use ofpsychotherapeutic drugs were excluded.</td>
</tr>
<tr>
<td colspan="2"><bold>5. Rossi et al, 2007<sup><xref ref-type="bibr" rid="bibr21-0194599812458771">21</xref></sup></bold></td>
</tr>
<tr>
<td><bold><italic>Inclusion criteria</italic></bold></td>
<td>Presence of mono- or bilateral tinnitus for more than 1 year, normal neurological examination, and normal cranialmagnetic resonance.</td>
</tr>
<tr>
<td><bold><italic>Exclusion criteria</italic></bold></td>
<td>History of neuropsychiatric disorders or neuroactive treatments (with the exception of antidepressant therapy previously taken for tinnitus therapy, withdrawn for at least 1 month) and presence of other significant medical illness.</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="fig1-0194599812458771" position="float">
<label>Figure 1.</label>
<caption><p>Flow diagram of search results.</p></caption>
<graphic xlink:href="10.1177_0194599812458771-fig1.tif"/>
</fig>
</sec>
<sec id="section18-0194599812458771">
<title>Trial Quality</title>
<p>The quality of allocation concealment was considered adequate in 2 trials and unclear in 3 trials. There were 4 trials mentioned in which blinding was used, and there was no mention in 1 trial. Incomplete outcome data were addressed in all 5 trials, and all trials were free of selective reporting and other bias (<xref ref-type="fig" rid="fig2-0194599812458771"><bold>Figure 2</bold></xref>).</p>
<fig id="fig2-0194599812458771" position="float">
<label>Figure 2.</label>
<caption><p>Characteristics of the trial quality. +, yes (low risk of bias); ?, unclear; –, no (high risk of bias).</p></caption>
<graphic xlink:href="10.1177_0194599812458771-fig2.tif"/>
</fig>
</sec>
<sec id="section19-0194599812458771">
<title>Effects of Interventions</title>
<p>Repetitive TMS showed a benefit in the short term, but the long-term effects are questionable. The THI and the VAS were the major assessment methods (<xref ref-type="table" rid="table2-0194599812458771"><bold>Table 2</bold></xref>). After active TMS stimulation, reductions in the THI and VAS scores were significant compared with baseline at the first assessment time point and in the short term (2 weeks and 4 weeks) (<xref ref-type="table" rid="table3-0194599812458771"><bold>Table 3</bold></xref>). The longest follow-up time was 26 weeks after treatment, and the shortest follow-up time was 2 weeks (<xref ref-type="table" rid="table4-0194599812458771"><bold>Table 4</bold></xref>). No severe side effects were reported from the use of rTMS. The left temporoparietal cortex was used as the stimulation position in 4 studies, and the stimulation parameters were 1 Hz, 5 daily sessions for 1 or 2 weeks (<xref ref-type="table" rid="table5-0194599812458771"><bold>Table 5</bold></xref>). Differences in age, hearing level, duration of tinnitus of the included patients, and the condition of sham treatment may influence the effect (<xref ref-type="table" rid="table5-0194599812458771"><bold>Tables 5</bold></xref> and <xref ref-type="table" rid="table6-0194599812458771"><bold>6</bold></xref>).</p>
<table-wrap id="table2-0194599812458771" position="float">
<label>Table 2.</label>
<caption><p>Assessment Methods of Included Trials</p></caption>
<graphic alternate-form-of="table2-0194599812458771" xlink:href="10.1177_0194599812458771-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="center">THI</th>
<th align="center">TQ</th>
<th align="center">VAS (VAS1, VAS2)</th>
<th align="center">HAM-A</th>
<th align="center">HAM-D</th>
<th align="center">TCS</th>
<th align="center">Self-rating of Tinnitus Annoyance</th>
<th align="center">Residual Inhibition</th>
<th align="center">Adverse Effects</th>
</tr>
</thead>
<tbody>
<tr>
<td>Anders et al, 2010<sup><xref ref-type="bibr" rid="bibr24-0194599812458771">24</xref></sup></td>
<td>√</td>
<td/>
<td>√</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Khedr et al, 2008<sup><xref ref-type="bibr" rid="bibr23-0194599812458771">23</xref></sup></td>
<td>√</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>√</td>
<td>√</td>
<td/>
</tr>
<tr>
<td>Marcondes et al, 2010<sup><xref ref-type="bibr" rid="bibr22-0194599812458771">22</xref></sup></td>
<td>√</td>
<td/>
<td>√</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Plewnia et al, 2007<sup><xref ref-type="bibr" rid="bibr25-0194599812458771">25</xref></sup></td>
<td/>
<td>√</td>
<td>√</td>
<td/>
<td/>
<td>√</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Rossi et al, 2007<sup><xref ref-type="bibr" rid="bibr21-0194599812458771">21</xref></sup></td>
<td/>
<td/>
<td>√</td>
<td>√</td>
<td>√</td>
<td/>
<td/>
<td/>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0194599812458771">
<p>Abbreviations: HAM-A, Hamilton Anxiety Scale; HAM-D, Hamilton Depression Rating Scale; TCS, tinnitus-change score; THI, Tinnitus Handicap Inventory; TQ, Tinnitus Questionnaire; VAS, visual analog scale.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table3-0194599812458771" position="float">
<label>Table 3.</label>
<caption><p>Results/Findings of Included Trials</p></caption>
<graphic alternate-form-of="table3-0194599812458771" xlink:href="10.1177_0194599812458771-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="center">Design</th>
<th align="center">No. Participants</th>
<th align="center">Results/Findings</th>
</tr>
</thead>
<tbody>
<tr>
<td>Anders et al, 2010<sup><xref ref-type="bibr" rid="bibr24-0194599812458771">24</xref></sup></td>
<td>Randomized, placebo controlled</td>
<td>52</td>
<td>1. There was a significant reduction between real and sham TMS groups in THI and TQ total score in the short term (week 2).</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>2. The reduction of TQ in the TMS group persisted to week 14 but only to week 2 in the sham group.</td>
</tr>
<tr>
<td>Khedr et al, 2008<sup><xref ref-type="bibr" rid="bibr23-0194599812458771">23</xref></sup></td>
<td>Randomized, computer generated</td>
<td>66</td>
<td>1. THI scores decreased significantly in TMS groups (temporoparietal) but were unchanged in the sham group (occipital).</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>2. Decreased annoyance ratings were greater with rTMS (temporoparietal) than with sham (occipital) stimulation.</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>3. Duration of residual inhibition increased significantly more after rTMS (temporoparietal) than sham (occipital).</td>
</tr>
<tr>
<td>Marcondes et al, 2010<sup><xref ref-type="bibr" rid="bibr22-0194599812458771">22</xref></sup></td>
<td>Randomized, double-blind controlled</td>
<td>20</td>
<td>1. There was a significant reduction in the total THI score at 1 and 6 months after rTMS.</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>2. There were no significant changes in the sham group at any time point.</td>
</tr>
<tr>
<td>Plewnia et al, 2007<sup><xref ref-type="bibr" rid="bibr25-0194599812458771">25</xref></sup></td>
<td>Randomized, controlled</td>
<td>6</td>
<td>1. The TQ score was reduced after rTMS compared with baseline and sham stimulation.</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>2. Tinnitus distress returned to baseline in 5 patients 2 weeks after treatment.</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>3. All 6 patients showed a benefit from rTMS in terms of tinnitus loudness and annoyance vs sham stimulation.</td>
</tr>
<tr>
<td>Rossi et al, 2007<sup><xref ref-type="bibr" rid="bibr21-0194599812458771">21</xref></sup></td>
<td>Randomized, crossover, double-blind, placebo controlled</td>
<td>16</td>
<td>1. The mean VAS score was significantly reduced at the end of active treatment and after 1 week of the true rTMS, whereas the difference was not significant after 2 weeks; however, the mean VAS score was not significantly changed by the sham.</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>2. HAM-A and HAM-D scores were not influenced by true or sham rTMS.</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0194599812458771">
<p>Abbreviations: HAM-A, Hamilton Anxiety Scale; HAM-D, Hamilton Depression Rating Scale; rTMS, repetitive transcranial magnetic stimulation; THI, Tinnitus Handicap Inventory; TMS, transcranial magnetic stimulation; TQ, Tinnitus Questionnaire; VAS, visual analog scale.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table4-0194599812458771" position="float">
<label>Table 4.</label>
<caption><p>Assessment Time of Included Trials</p></caption>
<graphic alternate-form-of="table4-0194599812458771" xlink:href="10.1177_0194599812458771-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center" colspan="12">Time<hr/></th>
</tr>
<tr>
<th align="left">Study</th>
<th align="center">Pre</th>
<th align="center">End</th>
<th align="center">P1</th>
<th align="center">P2</th>
<th align="center">P3</th>
<th align="center">P4</th>
<th align="center">P6</th>
<th align="center">P8</th>
<th align="center">P12</th>
<th align="center">P14-16</th>
<th align="center">P20-21</th>
<th align="center">P24-26</th>
</tr>
</thead>
<tbody>
<tr>
<td>Anders et al, 2010<sup><xref ref-type="bibr" rid="bibr24-0194599812458771">24</xref></sup></td>
<td>√</td>
<td>√</td>
<td/>
<td/>
<td/>
<td/>
<td>√</td>
<td/>
<td/>
<td>√</td>
<td/>
<td>√</td>
</tr>
<tr>
<td>Khedr et al, 2008<sup><xref ref-type="bibr" rid="bibr23-0194599812458771">23</xref></sup></td>
<td>√</td>
<td>√</td>
<td/>
<td/>
<td/>
<td>√</td>
<td/>
<td>√</td>
<td>√</td>
<td>√</td>
<td/>
<td/>
</tr>
<tr>
<td>Marcondes et al, 2010<sup><xref ref-type="bibr" rid="bibr22-0194599812458771">22</xref></sup></td>
<td>√</td>
<td/>
<td>√</td>
<td>√</td>
<td>√</td>
<td>√</td>
<td/>
<td>√</td>
<td>√</td>
<td>√</td>
<td>√</td>
<td>√</td>
</tr>
<tr>
<td>Plewnia et al, 2007<sup><xref ref-type="bibr" rid="bibr25-0194599812458771">25</xref></sup></td>
<td>√</td>
<td>√</td>
<td/>
<td/>
<td/>
<td>√</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Rossi et al. 2007<sup><xref ref-type="bibr" rid="bibr21-0194599812458771">21</xref></sup></td>
<td/>
<td>√</td>
<td>√</td>
<td>√</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0194599812458771">
<p>Abbreviations: Pre, time before the treatment; End: time at the end of treatment; P1, 1 week after treatment . . . P24-26, 24-26 weeks after treatment.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table5-0194599812458771" position="float">
<label>Table 5.</label>
<caption><p>Characteristics of Interventions of Included Trials</p></caption>
<graphic alternate-form-of="table5-0194599812458771" xlink:href="10.1177_0194599812458771-table5.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="center">Position</th>
<th align="center">Frequency</th>
<th align="center">Timing of Treatment</th>
<th align="center">Sham</th>
</tr>
</thead>
<tbody>
<tr>
<td>Anders et al, 2010<sup><xref ref-type="bibr" rid="bibr24-0194599812458771">24</xref></sup></td>
<td>Left temporoparietal cortex</td>
<td>1 Hz</td>
<td>5 daily sessions for 2 weeks</td>
<td>Given by tilting the coil 45° away from the skull</td>
</tr>
<tr>
<td>Khedr et al, 2008<sup><xref ref-type="bibr" rid="bibr23-0194599812458771">23</xref></sup></td>
<td>Left temporoparietal cortex</td>
<td>1 Hz; 10 Hz; 25 Hz</td>
<td>5 daily sessions for 2 weeks</td>
<td>Given over the Oz EEG site</td>
</tr>
<tr>
<td>Marcondes et al, 2010<sup><xref ref-type="bibr" rid="bibr22-0194599812458771">22</xref></sup></td>
<td>Left temporoparietal cortex</td>
<td>1 Hz</td>
<td>5 daily sessions for 1 week</td>
<td>Given with a sham coil system, which mimics the sound of active stimulation, without producing a magnetic field</td>
</tr>
<tr>
<td>Plewnia et al, 2007<sup><xref ref-type="bibr" rid="bibr25-0194599812458771">25</xref></sup></td>
<td>The region with maximal tinnitus-related increase by functional imaging with [<sup><xref ref-type="bibr" rid="bibr15-0194599812458771">15</xref></sup>O]H<sub>2</sub>O</td>
<td>1 Hz</td>
<td>Crossover design; 5 daily sessions for 2 weeks (TMS), then 5 daily sessions for 2 weeks (sham)</td>
<td>The coil was placed at the lower occiput at the same distance to the ear; the control stimulation was accompanied by a similar noise</td>
</tr>
<tr>
<td>Rossi et al, 2007<sup><xref ref-type="bibr" rid="bibr21-0194599812458771">21</xref></sup></td>
<td>Left temporoparietal region</td>
<td>1 Hz</td>
<td>Crossover design; 5 daily sessions for 2 weeks (TMS), then 5 daily sessions for 2 weeks (sham)</td>
<td>The coil was angled backward by about 45° away from the midline</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-0194599812458771">
<p>Abbreviations: EEG, electroencephalogram; TMS, transcranial magnetic stimulation.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table6-0194599812458771" position="float">
<label>Table 6.</label>
<caption><p>Characteristics of Participants in Included Trials</p></caption>
<graphic alternate-form-of="table6-0194599812458771" xlink:href="10.1177_0194599812458771-table6.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="center">Age</th>
<th align="center">Tinnitus Characteristic</th>
<th align="center">Hearing Testing</th>
</tr>
</thead>
<tbody>
<tr>
<td>Anders et al, 2010<sup><xref ref-type="bibr" rid="bibr24-0194599812458771">24</xref></sup></td>
<td>rTMS group: mean, 48.09 y; min, 20 y; max, 69 y</td>
<td>No description</td>
<td>All normal</td>
</tr>
<tr>
<td/>
<td>Sham group: mean, 50.05 y; min, 27 y; max, 66 y</td>
<td/>
<td/>
</tr>
<tr>
<td>Khedr et al, 2008<sup><xref ref-type="bibr" rid="bibr23-0194599812458771">23</xref></sup></td>
<td>Mean, 41 ± 15 y</td>
<td>Bilateral, n = 12; left side, n = 32; right side, n = 22</td>
<td>Normal, n = 53; 40 dB, n = 5; 40-55 dB, n = 5; 70 dB, n = 5</td>
</tr>
<tr>
<td>Marcondes et al, 2010<sup><xref ref-type="bibr" rid="bibr22-0194599812458771">22</xref></sup></td>
<td>Older than 18 years; no details</td>
<td>No description</td>
<td>All normal</td>
</tr>
<tr>
<td>Plewnia et al, 2007<sup><xref ref-type="bibr" rid="bibr25-0194599812458771">25</xref></sup></td>
<td>Range, 49 to 68 y</td>
<td>Bilateral</td>
<td>4 patients had high-frequency hearing loss; 2 patients had pancochlear hearing loss</td>
</tr>
<tr>
<td>Rossi et al, 2007<sup><xref ref-type="bibr" rid="bibr21-0194599812458771">21</xref></sup></td>
<td>Range, 35 to 72 y</td>
<td>Bilateral, n = 7; left side, n = 4; right side, n = 3</td>
<td>No description</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-0194599812458771">
<p>Abbreviation: rTMS, repetitive transcranial magnetic stimulation.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The 5 included studies were varied in design, with significant evaluation of subjective tinnitus perception with different scores, scales, tests, and questionnaires. Therefore, meta-analysis was not performed in this study.</p>
</sec>
</sec>
<sec id="section20-0194599812458771" sec-type="discussion">
<title>Discussion</title>
<sec id="section21-0194599812458771">
<title>Summary of the Main Results</title>
<p>Three included studies used the THI as the primary outcome to assess the treatment effect of tinnitus (<xref ref-type="table" rid="table2-0194599812458771"><bold>Table 2</bold></xref>). After active TMS stimulation, the reduction of the THI total score was significant compared with baseline at the first assessed time point. In the Anders et al<sup><xref ref-type="bibr" rid="bibr24-0194599812458771">24</xref></sup> study, the reduction of the total THI score only persisted to week 26 (<italic>P</italic> = .058) after TMS stimulation and to month 6 (<italic>P</italic> = 0.496) after TMS stimulation in the Marcondes et al<sup><xref ref-type="bibr" rid="bibr22-0194599812458771">22</xref></sup> study. The VAS score in the Rossi et al<sup><xref ref-type="bibr" rid="bibr21-0194599812458771">21</xref></sup> study also suggested only a transient improvement in perception of tinnitus after TMS. Therefore, the short-term effect of TMS for tinnitus is more obvious than the long-term effects, and further studies will be needed to determine the long-term effects.</p>
<p>Repetitive TMS is a safe treatment for chronic tinnitus, and the side effects observed were mild and tolerable. Studies regarding the use of rTMS for chronic tinnitus showed that the severity of tinnitus could be reduced by rTMS.<sup><xref ref-type="bibr" rid="bibr21-0194599812458771">21</xref><xref ref-type="bibr" rid="bibr22-0194599812458771"/><xref ref-type="bibr" rid="bibr23-0194599812458771"/><xref ref-type="bibr" rid="bibr24-0194599812458771"/>-<xref ref-type="bibr" rid="bibr25-0194599812458771">25</xref></sup> Because tinnitus is a subjective symptom, it is hard to evaluate via objective criteria, and the trials included were highly heterogeneous. The heterogeneity that we considered included inclusion and exclusion criteria (these include the duration of tinnitus, as well as the age and hearing level of the included patients), stimulation parameters, follow-up period, and assessment methods.</p>
</sec>
<sec id="section22-0194599812458771">
<title>Duration of Tinnitus</title>
<p>Auditory system plasticity has been recognized as an important change resulting from tinnitus.<sup><xref ref-type="bibr" rid="bibr26-0194599812458771">26</xref>,<xref ref-type="bibr" rid="bibr27-0194599812458771">27</xref></sup> The degree of maladaptive neuroplastic changes in auditory and nonauditory brain structures may depend on tinnitus duration. The effects of rTMS also depend on the history of synaptic activity of the stimulated brain region.<sup><xref ref-type="bibr" rid="bibr12-0194599812458771">12</xref></sup> Although this study included patients with chronic tinnitus, the duration of tinnitus was varied. Khedr et al<sup><xref ref-type="bibr" rid="bibr23-0194599812458771">23</xref></sup> showed that the response to rTMS depended on the duration of tinnitus. This is likely because the central network became less plastic if the duration of tinnitus was too long, rendering it less responsive to rTMS interference. The duration of tinnitus of the included patients ranged from 3 months to 25 years,<sup><xref ref-type="bibr" rid="bibr21-0194599812458771">21</xref><xref ref-type="bibr" rid="bibr22-0194599812458771"/><xref ref-type="bibr" rid="bibr23-0194599812458771"/><xref ref-type="bibr" rid="bibr24-0194599812458771"/>-<xref ref-type="bibr" rid="bibr25-0194599812458771">25</xref></sup> making it difficult to merge the outcomes in a simple way. A more exact inclusion criterion would be more conducive to assessing the efficacy of intervention. Also, if the most appropriate patients could be selected to receive the intervention, more patients would benefit, reducing unnecessary treatment.</p>
</sec>
<sec id="section23-0194599812458771">
<title>Hearing Level</title>
<p>Hearing loss in addition to tinnitus largely increases the related distress. It is widely assumed that deprivation of afferent input caused by hearing damage leads to a reduction of inhibition in central auditory structures, which results in hyperexcitability of circumscribed regions of the central auditory system.<sup><xref ref-type="bibr" rid="bibr28-0194599812458771">28</xref>,<xref ref-type="bibr" rid="bibr29-0194599812458771">29</xref></sup> This may be a crucial step in the development of subjective tinnitus. For that reason, chronic hearing impairment might attenuate the effects of rTMS by continuously triggering neuroplastic changes in central auditory structures. Two studies<sup><xref ref-type="bibr" rid="bibr23-0194599812458771">23</xref>,<xref ref-type="bibr" rid="bibr25-0194599812458771">25</xref></sup> included patients in whom hearing levels were unequal. Nineteen patients suffered mild to severe hearing loss. However, 2 separate studies<sup><xref ref-type="bibr" rid="bibr21-0194599812458771">21</xref>,<xref ref-type="bibr" rid="bibr22-0194599812458771">22</xref></sup> recruited patients with normal hearing. Yet another study did not describe hearing levels.<sup><xref ref-type="bibr" rid="bibr21-0194599812458771">21</xref></sup> Marcondes et al<sup><xref ref-type="bibr" rid="bibr22-0194599812458771">22</xref></sup> showed that baseline scores of the THI were relatively low because they only included patients with a normal audiogram. This suggests that hearing loss may be a negative predictor for the effects of rTMS treatment outcome. The relationship between hearing loss and tinnitus is still unknown, but the mechanisms involved in simple tinnitus and those involved in hearing loss in addition to tinnitus may be different. As a result, we feel it will be necessary to perform a subgroup analysis to make the results more reliable.</p>
</sec>
<sec id="section24-0194599812458771">
<title>Age</title>
<p>Neuroplastic processes play a crucial role in both the generation of tinnitus and the degree of suffering.<sup><xref ref-type="bibr" rid="bibr30-0194599812458771">30</xref></sup> Many aspects of brain structure, function, and plasticity change with age in a complex way.<sup><xref ref-type="bibr" rid="bibr31-0194599812458771">31</xref></sup> Both the generation of tinnitus and the amount of tinnitus distress are thought to depend on adaptive and compensatory brain mechanisms.<sup><xref ref-type="bibr" rid="bibr32-0194599812458771">32</xref></sup> Age strongly influences tinnitus prevalence,<sup><xref ref-type="bibr" rid="bibr33-0194599812458771">33</xref></sup> and “age of onset” has been added as an additional factor underscoring the relevance of time-related aspects in the pathophysiology of tinnitus.<sup><xref ref-type="bibr" rid="bibr34-0194599812458771">34</xref></sup> Information regarding age in 5 of the included trials is shown in <xref ref-type="table" rid="table6-0194599812458771"><bold>Table 6</bold></xref>. All the participants were older than 18 years, but none of the trials divided the patients by age. One study acknowledged that patients’ age played a role and that it would be appropriate to divide the sample into age clusters.<sup><xref ref-type="bibr" rid="bibr24-0194599812458771">24</xref></sup> However, it was impossible for us to divide the patients into subgroups by age because the included studies did not provide details regarding the ages of patients. In fact, 1 study determined that age did not influence tinnitus annoyance as assessed by the THI.<sup><xref ref-type="bibr" rid="bibr35-0194599812458771">35</xref></sup> Therefore, more work must be done to determine the role of age in this process.</p>
</sec>
<sec id="section25-0194599812458771">
<title>Stimulation Parameters</title>
<p>The stimulation parameters included control conditions, frequency, intensity, and coil localization. Finding an optimal control condition for treatment studies is also difficult, owing to limitations in the ability to blind the patient and operator to different stimulus conditions and because TMS itself results in auditory and somatosensory stimulation in addition to actual brain site–specific effects.</p>
<p>The design of the sham group was also a source of heterogeneity. Sham was performed over the Oz electroencephalogram (EEG) site in the Khedr et al<sup><xref ref-type="bibr" rid="bibr23-0194599812458771">23</xref></sup> study and given with a sham coil system that mimics the sound of active stimulation, without producing a magnetic field, in the Marcondes et al<sup><xref ref-type="bibr" rid="bibr22-0194599812458771">22</xref></sup> study. This was carried out by tilting the coil 45° away from the skull with 1 wing touching the skull in the Anders et al<sup><xref ref-type="bibr" rid="bibr24-0194599812458771">24</xref></sup> study. Control conditions were a limitation of these studies, as the sham coil can mimic the sound of active rTMS but lacks somatosensory sensation. Controlling for somatosensory stimulation seemed to be critical since somatosensory input was able to modulate tinnitus sensation.<sup><xref ref-type="bibr" rid="bibr36-0194599812458771">36</xref></sup> Also, Anders et al<sup><xref ref-type="bibr" rid="bibr24-0194599812458771">24</xref></sup> speculated that subjects can easily distinguish the difference between real and sham stimulation. However, patients were not able to identify whether they were stimulated with active or sham rTMS. Therefore, the crossover design studies may have an advantage, as they contained a self-controlling group as a sham group, as opposed to other studies.<sup><xref ref-type="bibr" rid="bibr21-0194599812458771">21</xref>,<xref ref-type="bibr" rid="bibr25-0194599812458771">25</xref></sup></p>
<p>The amount of tinnitus suppression was correlated positively with stimulation frequency.<sup><xref ref-type="bibr" rid="bibr37-0194599812458771">37</xref></sup> Most rTMS is performed in long trains of 1200 to 2000 pulses repeatedly over 5 to 10 days.</p>
<p>Both animal models and functional imaging data in tinnitus patients suggest that tinnitus is associated with increased neuronal activity, increased synchronicity, and functional reorganization in the auditory cortex.<sup><xref ref-type="bibr" rid="bibr38-0194599812458771">38</xref>,<xref ref-type="bibr" rid="bibr39-0194599812458771">39</xref></sup> As a result, different functional neuroimaging techniques are used to detect tinnitus-related changes in the brain. These converge in the finding of increased neuronal activity in the central auditory system but differ in the exact localization of these changes, which in turn results in uncertainty regarding the optimal target for rTMS treatment. Currently available studies do not demonstrate clear evidence for the superiority of neuronavigational coil positioning.<sup><xref ref-type="bibr" rid="bibr40-0194599812458771">40</xref></sup></p>
<p>Further development of rTMS as a treatment for tinnitus will depend on a more detailed understanding of both the neuronal correlates of the different forms of tinnitus and of the neurobiological effects mediating the benefit of TMS on tinnitus perception.</p>
</sec>
<sec id="section26-0194599812458771">
<title>Follow-up Period</title>
<p>The follow-up periods were different in the included studies. There was not enough evidence from the available literature to determine whether the follow-up period was suitable to assess the treatment effect of rTMS for tinnitus. Through the included studies, we concluded that pretreatment and end-of-treatment time points were necessary but that the follow-up period must be determined through further study.</p>
</sec>
<sec id="section27-0194599812458771">
<title>Assessment Methods</title>
<p>Tinnitus is a purely subjective phenomenon that is difficult to measure. An expert consensus for treatment outcome measurements in tinnitus patients has been published only recently.<sup><xref ref-type="bibr" rid="bibr41-0194599812458771">41</xref></sup></p>
<p>However, the intensity of tinnitus, as well as the amount of distress, annoyance, and impact on daily living, is important to determine. The methods for assessing tinnitus in the included studies mainly included the THI, VAS, tinnitus-change score (TCS), and self-rating of tinnitus annoyance and residual inhibition. The THI was used in 3 studies.<sup><xref ref-type="bibr" rid="bibr22-0194599812458771">22</xref><xref ref-type="bibr" rid="bibr23-0194599812458771"/>-<xref ref-type="bibr" rid="bibr24-0194599812458771">24</xref></sup> The THI score included total score and several domains (physical, emotional, and catastrophic). The VAS was used in the Rossi et al<sup><xref ref-type="bibr" rid="bibr21-0194599812458771">21</xref></sup> study, and TCS was used in the Plewnia et al<sup><xref ref-type="bibr" rid="bibr25-0194599812458771">25</xref></sup> study. Because of the subjective nature of tinnitus, standards are required to evaluate the effects of rTMS.</p>
<p>The evidence to support (or refute) the use of rTMS in the management of tinnitus was not definite. We encountered difficulties in extracting the benefit from rTMS therapy from scales with different standards. Some studies used dichotomous data to express outcome, such as the Khedr et al<sup><xref ref-type="bibr" rid="bibr23-0194599812458771">23</xref></sup> study. We contacted the author for raw data, but no further information was available at the time of manuscript preparation. We found a study protocol describing the design of a placebo-controlled, randomized study of the use of rTMS for chronic tinnitus by Landgrebe et al,<sup><xref ref-type="bibr" rid="bibr42-0194599812458771">42</xref></sup> published in 2008. The duration of this study is estimated to be about 3 years, and it will provide more information regarding the efficacy of rTMS in the treatment of chronic tinnitus in the near future.</p>
<p>Except for subjective assessment, an increasing amount of data from pilot studies indicates considerable potential for a variety of electrophysiological and neuroimaging methods to assess alterations in brain structure and function in patients with tinnitus.<sup><xref ref-type="bibr" rid="bibr41-0194599812458771">41</xref></sup> A study by Smith et al<sup><xref ref-type="bibr" rid="bibr19-0194599812458771">19</xref></sup> demonstrated for the first time that an improvement in tinnitus rating after stimulation was reflected by a reduction of activity in the positron emission tomography (PET) scan after rTMS when compared with pretreatment values. Therefore, functional imaging might represent an important objective marker of treatment effects in the future.<sup><xref ref-type="bibr" rid="bibr37-0194599812458771">37</xref></sup></p>
</sec>
</sec>
<sec id="section28-0194599812458771" sec-type="conclusions">
<title>Conclusion</title>
<p>Repetitive TMS provides a new therapeutic tool for chronic tinnitus. Even though the quantity of improvement varied across studies, a stable, statistically significant improvement in tinnitus complaints could be observed. Differences in study design, stimulation parameters, and patient population render a further comparison of results difficult, and the long-term outcome of positive effects will require further study.</p>
<p>Moreover, the most effective stimulation parameters, particularly the optimal brain area and hemisphere, as well as the most favorable treatment schedules, are unknown. This has given rise to several attempts to optimize treatment strategies.</p>
<p>Future studies should be based on a consensus as to the most appropriate outcome measures of tinnitus. There is currently not enough evidence to determine a correlation between the duration of tinnitus and the effects of rTMS, and more work must be done to clarify this in the near future, if optimization of treatment strategies is to be achieved.</p>
</sec>
<sec id="section29-0194599812458771">
<title>Author Contributions</title>
<p><bold>Zhe Peng</bold>, writing the article, searching, selection of studies, data extraction, drafting and co-drafting of the protocol/review, assistance with statistics, data analysis and data presentation; <bold>Xiu-Qi Chen</bold>, selection of studies, data extraction, assistance with statistics, data analysis; <bold>Shu-Sheng Gong</bold>, lead author, selection of studies, assistance with statistics.</p>
</sec>
<sec id="section30-0194599812458771">
<title>Disclosures</title>
<p><bold>Competing interests:</bold> None.</p>
<p><bold>Sponsorships:</bold> None.</p>
<p><bold>Funding source:</bold> Major State Basic Research Development Program of China (973 Program) (No. 2011CB504503), Beijing Science and Technology Program (No. KZ201210025026), and National Key Technology R&amp;D Program (No. 2012BA112B05).</p>
</sec>
</body>
<back>
<ack>
<p>We thank Martin Anders et al for providing their article and data, as well as Zhang-bin Yu and Da-hua Wu for revision of the manuscript.</p>
</ack>
<fn-group>
<fn fn-type="presented-at">
<p>Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0194599812458771">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Luxon</surname><given-names>LM</given-names></name>
</person-group>. <article-title>Tinnitus: its causes, diagnosis, and treatment</article-title>. <source>BMJ</source>. <year>1993</year>;<volume>306</volume>:<fpage>1490</fpage>-<lpage>1491</lpage>.</citation>
</ref>
<ref id="bibr2-0194599812458771">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Henry</surname><given-names>JA</given-names></name>
<name><surname>Dennis</surname><given-names>KC</given-names></name>
<name><surname>Schechter</surname><given-names>MA</given-names></name>
</person-group>. <article-title>General review of tinnitus: prevalence, mechanisms, effects, and management</article-title>. <source>J Speech Lang Hear Res</source>. <year>2005</year>;<volume>48</volume>:<fpage>1204</fpage>-<lpage>1235</lpage>.</citation>
</ref>
<ref id="bibr3-0194599812458771">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moller</surname><given-names>AR</given-names></name>
</person-group>. <article-title>Tinnitus and pain</article-title>. <source>Prog Brain Res</source>. <year>2007</year>;<volume>166</volume>:<fpage>47</fpage>-<lpage>53</lpage>.</citation>
</ref>
<ref id="bibr4-0194599812458771">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chan</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Tinnitus: etiology, classification, characteristics, and treatment</article-title>. <source>Discov Med</source>. <year>2009</year>;<volume>8</volume>:<fpage>133</fpage>-<lpage>136</lpage>.</citation>
</ref>
<ref id="bibr5-0194599812458771">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dobie</surname><given-names>RA</given-names></name>
</person-group>. <article-title>Depression and tinnitus</article-title>. <source>Otolaryngol Clin North Am</source>. <year>2003</year>;<volume>36</volume>:<fpage>383</fpage>-<lpage>388</lpage>.</citation>
</ref>
<ref id="bibr6-0194599812458771">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stouffer</surname><given-names>JL</given-names></name>
<name><surname>Tyler</surname><given-names>RS</given-names></name>
</person-group>. <article-title>Characterization of tinnitus by tinnitus patients</article-title>. <source>J Speech Hear Disord</source>. <year>1990</year>;<volume>55</volume>:<fpage>439</fpage>-<lpage>453</lpage>.</citation>
</ref>
<ref id="bibr7-0194599812458771">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Seidman</surname><given-names>MD</given-names></name>
<name><surname>Standring</surname><given-names>RT</given-names></name>
<name><surname>Dornhoffer</surname><given-names>JL</given-names></name>
</person-group>. <article-title>Tinnitus: current understanding and contemporary management</article-title>. <source>Curr Opin Otolaryngol Head Neck Surg</source>. <year>2010</year>;<volume>18</volume>:<fpage>363</fpage>-<lpage>368</lpage>.</citation>
</ref>
<ref id="bibr8-0194599812458771">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lockwood</surname><given-names>AH</given-names></name>
<name><surname>Salvi</surname><given-names>RJ</given-names></name>
<name><surname>Burkard</surname><given-names>RF</given-names></name>
</person-group>. <article-title>Tinnitus</article-title>. <source>N Engl J Med</source>. <year>2002</year>;<volume>347</volume>:<fpage>904</fpage>-<lpage>910</lpage>.</citation>
</ref>
<ref id="bibr9-0194599812458771">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Minami</surname><given-names>SB</given-names></name>
<name><surname>Shinden</surname><given-names>S</given-names></name>
<name><surname>Okamoto</surname><given-names>Y</given-names></name>
<etal/>
</person-group>. <article-title>Repetitive transcranial magnetic stimulation (rTMS) for treatment of chronic tinnitus</article-title>. <source>Auris Nasus Larynx</source>. <year>2011</year>;<volume>38</volume>:<fpage>301</fpage>-<lpage>306</lpage>.</citation>
</ref>
<ref id="bibr10-0194599812458771">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barker</surname><given-names>AT</given-names></name>
<name><surname>Jalinous</surname><given-names>R</given-names></name>
<name><surname>Freeston</surname><given-names>IL</given-names></name>
</person-group>. <article-title>Non-invasive magnetic stimulation of human motor cortex</article-title>. <source>Lancet</source>. <year>1985</year>;<volume>1</volume>:<fpage>1106</fpage>-<lpage>1107</lpage>.</citation>
</ref>
<ref id="bibr11-0194599812458771">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Siebner</surname><given-names>HR</given-names></name>
<name><surname>Rothwell</surname><given-names>J</given-names></name>
</person-group>. <article-title>Transcranial magnetic stimulation: new insights into representational cortical plasticity</article-title>. <source>Exp Brain Res</source>. <year>2003</year>;<volume>148</volume>:<fpage>1</fpage>-<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr12-0194599812458771">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ridding</surname><given-names>MC</given-names></name>
<name><surname>Rothwell</surname><given-names>JC</given-names></name>
</person-group>. <article-title>Therapeutic use of rTMS</article-title>. <source>Nat Rev Neurosci</source>. <year>2007</year>;<volume>8</volume>:<fpage>559</fpage>-<lpage>567</lpage>.</citation>
</ref>
<ref id="bibr13-0194599812458771">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>De Ridder</surname><given-names>D</given-names></name>
<name><surname>De Mulder</surname><given-names>G</given-names></name>
<name><surname>Walsh</surname><given-names>V</given-names></name>
<name><surname>Muggleton</surname><given-names>N</given-names></name>
<name><surname>Sunaert</surname><given-names>S</given-names></name>
<name><surname>Møller</surname><given-names>A</given-names></name>
</person-group>. <article-title>Magnetic and electrical stimulation of the auditory cortex for intractable tinnitus: case report</article-title>. <source>J Neurosurg</source>. <year>2004</year>;<volume>100</volume>:<fpage>560</fpage>-<lpage>564</lpage>.</citation>
</ref>
<ref id="bibr14-0194599812458771">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Eichhammer</surname><given-names>P</given-names></name>
<name><surname>Langguth</surname><given-names>B</given-names></name>
<name><surname>Marienhagen</surname><given-names>J</given-names></name>
<name><surname>Kleinjung</surname><given-names>T</given-names></name>
<name><surname>Hajak</surname><given-names>G</given-names></name>
</person-group>. <article-title>Neuronavigated repetitive transcranial magnetic stimulation in patients with tinnitus: a short case series</article-title>. <source>Biol Psychiatry</source>. <year>2003</year>;<volume>54</volume>:<fpage>862</fpage>-<lpage>865</lpage>.</citation>
</ref>
<ref id="bibr15-0194599812458771">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Langguth</surname><given-names>B</given-names></name>
<name><surname>Eichhammer</surname><given-names>P</given-names></name>
<name><surname>Wiegand</surname><given-names>R</given-names></name>
<etal/>
</person-group>. <article-title>Neuronavigated rTMS in a patient with chronic tinnitus: effects of 4 weeks treatment</article-title>. <source>Neuroreport</source>. <year>2003</year>;<volume>14</volume>:<fpage>977</fpage>-<lpage>980</lpage>.</citation>
</ref>
<ref id="bibr16-0194599812458771">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Plewnia</surname><given-names>C</given-names></name>
<name><surname>Bartels</surname><given-names>M</given-names></name>
<name><surname>Gerloff</surname><given-names>C</given-names></name>
</person-group>. <article-title>Transient suppression of tinnitus by transcranial magnetic stimulation</article-title>. <source>Ann Neurol</source>. <year>2003</year>;<volume>53</volume>:<fpage>263</fpage>-<lpage>236</lpage>.</citation>
</ref>
<ref id="bibr17-0194599812458771">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Newman</surname><given-names>CW</given-names></name>
<name><surname>Jacobson</surname><given-names>GP</given-names></name>
<name><surname>Spitzer</surname><given-names>JB</given-names></name>
</person-group>. <article-title>Development of the Tinnitus Handicap Inventory</article-title>. <source>Arch Otolaryngol Head Neck Surg</source>. <year>1996</year>;<volume>122</volume>:<fpage>143</fpage>-<lpage>148</lpage>.</citation>
</ref>
<ref id="bibr18-0194599812458771">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hallam</surname><given-names>RS</given-names></name>
<name><surname>Jakes</surname><given-names>SC</given-names></name>
<name><surname>Hinchcliffe</surname><given-names>R</given-names></name>
</person-group>. <article-title>Cognitive variables in tinnitus annoyance</article-title>. <source>Br J Clin Psychol</source>. <year>1988</year>;<volume>27</volume>:<fpage>213</fpage>-<lpage>222</lpage>.</citation>
</ref>
<ref id="bibr19-0194599812458771">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Smith</surname><given-names>JA</given-names></name>
<name><surname>Mennemeier</surname><given-names>M</given-names></name>
<name><surname>Bartel</surname><given-names>T</given-names></name>
<etal/>
</person-group>. <article-title>Repetitive transcranial magnetic stimulation for tinnitus: a pilot study</article-title>. <source>Laryngoscope</source>. <year>2007</year>;<volume>117</volume>:<fpage>529</fpage>-<lpage>534</lpage>.</citation>
</ref>
<ref id="bibr20-0194599812458771">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Khedr</surname><given-names>EM</given-names></name>
<name><surname>Abo-Elfetoh</surname><given-names>N</given-names></name>
<name><surname>Rothwell</surname><given-names>JC</given-names></name>
<name><surname>El-Atar</surname><given-names>A</given-names></name>
<name><surname>Sayed</surname><given-names>E</given-names></name>
<name><surname>Khalifa</surname><given-names>H</given-names></name>
</person-group>. <article-title>Contralateral versus ipsilateral rTMS of temporoparietal cortex for the treatment of chronic unilateral tinnitus: comparative study</article-title>. <source>Eur J Neurol</source>. <year>2010</year>;<volume>17</volume>:<fpage>976</fpage>-<lpage>983</lpage>.</citation>
</ref>
<ref id="bibr21-0194599812458771">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rossi</surname><given-names>S</given-names></name>
<name><surname>De Capua</surname><given-names>A</given-names></name>
<name><surname>Ulivelli</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Effects of repetitive transcranial magnetic stimulation on chronic tinnitus: a randomised, crossover, double blind, placebo controlled study</article-title>. <source>J Neurol Neurosurg Psychiatry</source>. <year>2007</year>;<volume>78</volume>:<fpage>857</fpage>-<lpage>863</lpage>.</citation>
</ref>
<ref id="bibr22-0194599812458771">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Marcondes</surname><given-names>RA</given-names></name>
<name><surname>Sanchez</surname><given-names>TG</given-names></name>
<name><surname>Kii</surname><given-names>MA</given-names></name>
<etal/>
</person-group>. <article-title>Repetitive transcranial magnetic stimulation improve tinnitus in normal hearing patients: a double-blind controlled, clinical and neuroimaging outcome study</article-title>. <source>Eur J Neurol</source>. <year>2010</year>;<volume>17</volume>:<fpage>38</fpage>-<lpage>44</lpage>.</citation>
</ref>
<ref id="bibr23-0194599812458771">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Khedr</surname><given-names>EM</given-names></name>
<name><surname>Rothwell</surname><given-names>JC</given-names></name>
<name><surname>Ahmed</surname><given-names>MA</given-names></name>
<name><surname>El-Atar</surname><given-names>A</given-names></name>
</person-group>. <article-title>Effect of daily repetitive transcranial magnetic stimulation for treatment of tinnitus: comparison of different stimulus frequencies</article-title>. <source>J Neurol Neurosurg Psychiatry</source>. <year>2008</year>;<volume>79</volume>:<fpage>212</fpage>-<lpage>215</lpage>.</citation>
</ref>
<ref id="bibr24-0194599812458771">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Anders</surname><given-names>M</given-names></name>
<name><surname>Dvorakova</surname><given-names>J</given-names></name>
<name><surname>Rathova</surname><given-names>L</given-names></name>
<etal/>
</person-group>. <article-title>Efficacy of repetitive transcranial magnetic stimulation for the treatment of refractory chronic tinnitus: a randomized, placebo controlled study</article-title>. <source>Neuro Endocrinol Lett</source>. <year>2010</year>;<volume>31</volume>:<fpage>238</fpage>-<lpage>249</lpage>.</citation>
</ref>
<ref id="bibr25-0194599812458771">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Plewnia</surname><given-names>C</given-names></name>
<name><surname>Reimold</surname><given-names>M</given-names></name>
<name><surname>Najib</surname><given-names>A</given-names></name>
<name><surname>Reischl</surname><given-names>G</given-names></name>
<name><surname>Plontke</surname><given-names>SK</given-names></name>
<name><surname>Gerloff</surname><given-names>C</given-names></name>
</person-group>. <article-title>Moderate therapeutic efficacy of positron emission tomography–navigated repetitive transcranial magnetic stimulation for chronic tinnitus: a randomised, controlled pilot study</article-title>. <source>J Neurol Neurosurg Psychiatry</source>. <year>2007</year>;<volume>78</volume>:<fpage>152</fpage>-<lpage>156</lpage>.</citation>
</ref>
<ref id="bibr26-0194599812458771">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mazurek</surname><given-names>B</given-names></name>
<name><surname>Olze</surname><given-names>H</given-names></name>
<name><surname>Haupt</surname><given-names>H</given-names></name>
<etal/>
</person-group>. <article-title>Molecular biological aspects of neuroplasticity: approaches for treating tinnitus and hearing disorders [in German]</article-title>. <source>HNO</source>. <year>2010</year>;<volume>58</volume>:<fpage>973</fpage>-<lpage>982</lpage>.</citation>
</ref>
<ref id="bibr27-0194599812458771">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mahlke</surname><given-names>C</given-names></name>
<name><surname>Wallhausser-Franke</surname><given-names>E</given-names></name>
</person-group>. <article-title>Evidence for tinnitus-related plasticity in the auditory and limbic system, demonstrated by arg3.1 and c-fos immunocytochemistry</article-title>. <source>Hear Res</source>. <year>2004</year>;<volume>195</volume>:<fpage>17</fpage>-<lpage>34</lpage>.</citation>
</ref>
<ref id="bibr28-0194599812458771">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Eggermont</surname><given-names>JJ</given-names></name>
<name><surname>Roberts</surname><given-names>LE</given-names></name>
</person-group>. <article-title>The neuroscience of tinnitus</article-title>. <source>Trends Neurosci</source>. <year>2004</year>;<volume>27</volume>:<fpage>676</fpage>-<lpage>682</lpage>.</citation>
</ref>
<ref id="bibr29-0194599812458771">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaltenbach</surname><given-names>JA</given-names></name>
</person-group>. <article-title>The dorsal cochlear nucleus as a participant in the auditory, attentional and emotional components of tinnitus</article-title>. <source>Hear Res</source>. <year>2006</year>;<volume>216-217</volume>:<fpage>224</fpage>-<lpage>234</lpage>.</citation>
</ref>
<ref id="bibr30-0194599812458771">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moller</surname><given-names>AR</given-names></name>
</person-group>. <article-title>The role of neural plasticity in tinnitus</article-title>. <source>Prog Brain Res</source>. <year>2007</year>;<volume>166</volume>:<fpage>37</fpage>-<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr31-0194599812458771">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Goh</surname><given-names>JO</given-names></name>
<name><surname>Park</surname><given-names>DC</given-names></name>
</person-group>. <article-title>Neuroplasticity and cognitive aging: the scaffolding theory of aging and cognition</article-title>. <source>Restor Neurol Neurosci</source>. <year>2009</year>;<volume>27</volume>:<fpage>391</fpage>-<lpage>403</lpage>.</citation>
</ref>
<ref id="bibr32-0194599812458771">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zollig</surname><given-names>J</given-names></name>
<name><surname>Eschen</surname><given-names>A</given-names></name>
</person-group>. <article-title>Measuring compensation and its plasticity across the lifespan</article-title>. <source>Restor Neurol Neurosci</source>. <year>2009</year>;<volume>27</volume>:<fpage>421</fpage>-<lpage>433</lpage>.</citation>
</ref>
<ref id="bibr33-0194599812458771">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shargorodsky</surname><given-names>J</given-names></name>
<name><surname>Curhan</surname><given-names>SG</given-names></name>
<name><surname>Curhan</surname><given-names>GC</given-names></name>
<name><surname>Eavey</surname><given-names>R</given-names></name>
</person-group>. <article-title>Change in prevalence of hearing loss in US adolescents</article-title>. <source>JAMA</source>. <year>2010</year>;<volume>304</volume>:<fpage>772</fpage>-<lpage>778</lpage>.</citation>
</ref>
<ref id="bibr34-0194599812458771">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schlee</surname><given-names>W</given-names></name>
<name><surname>Kleinjung</surname><given-names>T</given-names></name>
<name><surname>Hiller</surname><given-names>W</given-names></name>
<name><surname>Goebel</surname><given-names>G</given-names></name>
<name><surname>Kolassa</surname><given-names>IT</given-names></name>
<name><surname>Langguth</surname><given-names>B</given-names></name>
</person-group>. <article-title>Does tinnitus distress depend on age of onset?</article-title> <source>PLoS One</source>. <year>2011</year>;<volume>6</volume>:<fpage>e27379</fpage>.</citation>
</ref>
<ref id="bibr35-0194599812458771">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pinto</surname><given-names>PCL</given-names></name>
<name><surname>Sanchez</surname><given-names>TG</given-names></name>
<name><surname>Tomita</surname><given-names>S</given-names></name>
</person-group>. <article-title>The impact of gender, age and hearing loss on tinnitus severity</article-title>. <source>Braz J Otorhinolaryngol</source>. <year>2010</year>;<volume>76</volume>:<fpage>18</fpage>-<lpage>24</lpage>.</citation>
</ref>
<ref id="bibr36-0194599812458771">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moller</surname><given-names>AR</given-names></name>
</person-group>. <article-title>Pathophysiology of tinnitus</article-title>. <source>Otolaryngol Clin North Am</source>. <year>2003</year>;<volume>36</volume>:<fpage>249</fpage>-<lpage>66</lpage>, <fpage>v</fpage>-<lpage>vi</lpage>.</citation>
</ref>
<ref id="bibr37-0194599812458771">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kleinjung</surname><given-names>T</given-names></name>
<name><surname>Vielsmeier</surname><given-names>V</given-names></name>
<name><surname>Landgrebe</surname><given-names>M</given-names></name>
<name><surname>Hajak</surname><given-names>G</given-names></name>
<name><surname>Langguth</surname><given-names>B</given-names></name>
</person-group>. <article-title>Transcranial magnetic stimulation: a new diagnostic and therapeutic tool for tinnitus patients</article-title>. <source>Int Tinnitus J</source>. <year>2008</year>;<volume>14</volume>:<fpage>112</fpage>-<lpage>118</lpage>.</citation>
</ref>
<ref id="bibr38-0194599812458771">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Eggermont</surname><given-names>JJ</given-names></name>
</person-group>. <article-title>Pathophysiology of tinnitus</article-title>. <source>Prog Brain Res</source>. <year>2007</year>;<volume>166</volume>:<fpage>19</fpage>-<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr39-0194599812458771">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Eggermont</surname><given-names>JJ</given-names></name>
</person-group>. <article-title>Central tinnitus</article-title>. <source>Auris Nasus Larynx</source>. <year>2003</year>;<volume>30</volume>(<supplement>suppl</supplement>):<fpage>S7</fpage>-<lpage>S12</lpage>.</citation>
</ref>
<ref id="bibr40-0194599812458771">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Langguth</surname><given-names>B</given-names></name>
<name><surname>Kleinjung</surname><given-names>T</given-names></name>
<name><surname>Landgrebe</surname><given-names>M</given-names></name>
<name><surname>de Ridder</surname><given-names>D</given-names></name>
<name><surname>Hajak</surname><given-names>G</given-names></name>
</person-group>. <article-title>rTMS for the treatment of tinnitus: the role of neuronavigation for coil positioning</article-title>. <source>Neurophysiol Clin</source>. <year>2010</year>;<volume>40</volume>:<fpage>45</fpage>-<lpage>58</lpage>.</citation>
</ref>
<ref id="bibr41-0194599812458771">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Langguth</surname><given-names>B</given-names></name>
<name><surname>Goodey</surname><given-names>R</given-names></name>
<name><surname>Azevedo</surname><given-names>A</given-names></name>
<etal/>
</person-group>. <article-title>Consensus for tinnitus patient assessment and treatment outcome measurement: Tinnitus Research Initiative meeting, Regensburg, July 2006</article-title>. <source>Prog Brain Res</source>. <year>2007</year>;<volume>166</volume>:<fpage>525</fpage>-<lpage>536</lpage>.</citation>
</ref>
<ref id="bibr42-0194599812458771">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Landgrebe</surname><given-names>M</given-names></name>
<name><surname>Binder</surname><given-names>H</given-names></name>
<name><surname>Koller</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Design of a placebo-controlled, randomized study of the efficacy of repetitive transcranial magnetic stimulation for the treatment of chronic tinnitus</article-title>. <source>BMC Psychiatry</source>. <year>2008</year>;<volume>8</volume>:<fpage>23</fpage>.</citation>
</ref>
</ref-list>
</back>
</article>